CONDITION SPECIFIC ANTEPARTUM TESTING - SYSTEMIC LUPUS-ERYTHEMATOSUS AND ASSOCIATED SEROLOGIC ABNORMALITIES INTERNATIONAL CONF ON RHEUMATIC DISEASES IN PREGNANCY Adams, D., Druzin, M. L., Edersheim, T., Bond, A., Kogut, E. MUNKSGAARD INT PUBL LTD. 1992: 159–63

Abstract

Antepartum fetal surveillance is well established in the optimal management of any pregnancy complicated by maternal systemic lupus erythematosus and/or its associated serologic abnormalities. Our experience in antepartum surveillance of the "lupus pregnancy" from 1980 to 1988 is reviewed. An overall perinatal mortality rate of 6.06% compares favorably to the total intrauterine death rate range usually reported for this disease.

View details for Web of Science ID A1992KH72800012

View details for PubMedID 1285869